In addition, we analyzed survival probability of the cervical cancer patients with high NAT10 expression (n = 41) and that of low NAT10 expression (n = 14) in the GSE52904 dataset by the LOGpc data platform, and the results demonstrated that high expression of NAT10 was significantly associated with poor prognosis of cervical cancer patients (Fig. 1F), suggesting that NAT10 may be an important marker for the prognosis of cervical cancer patients. The gene discussed is NAT10; the disease is cervical carcinoma.